Ibex Investors LLC Lantheus Holdings, Inc. Transaction History

Ibex Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$14.85 - $24.3 $188,446 - $308,367	-12,690 Closed	0 $0
Q4 2017 Feb 27, 2019	SELL	$17.4 - $23.4 $2,853 - $3,837	-164 Reduced 1.28%	12,690 $263,000
Q4 2017 Nov 21, 2018	BUY	$17.4 - $23.4 $2,853 - $3,837	164 Added 1.29%	12,854 $263,000
Q4 2017 Feb 14, 2018	BUY	$17.4 - $23.4 $220,805 - $296,946	12,690	12,690 $259,000

538

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Ibex Investors LLC with notifications on news.